StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$37.75−1.03 (-2.66%)

Close on Nov 18, 2026Market cap $3.66BP/E –Yield –

Xenon Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Xenon Pharmaceuticals's total debt was $15.68M at Mar 31, 2020. For fiscal 2019 it was $15.54M, up 3.5% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$15.54M+3.5%
FY2018Dec 31, 2018$15.01M+120.7%
FY2017Dec 31, 2017$6.80M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2020Mar 31, 2020$15.68M+3.5%
Q4 FY2019Dec 31, 2019$15.54M+3.5%
Q3 FY2019Sep 30, 2019$15.40M+3.5%
Q2 FY2019Jun 30, 2019$15.27M+30.3%
Q1 FY2019Mar 31, 2019$15.14M+120.2%
Q4 FY2018Dec 31, 2018$15.01M+120.7%
Q3 FY2018Sep 30, 2018$14.89M–
Q2 FY2018Jun 30, 2018$11.72M–
Q1 FY2018Mar 31, 2018$6.88M–
Q4 FY2017Dec 31, 2017$6.80M–

More Xenon Pharmaceuticals figures

See a number that looks wrong?